Inhaled nicotine equivalent to cigarette smoking disrupts systemic and uterine hemodynamics and induces cardiac arrhythmia in pregnant rats

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Shao, Xuesi M ^a   López Valdés, Héctor E ^a,b   Liang, Jing ^a,c   Feldman, Jack L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85037063909     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-17301-5     Document Type: Article

References (31)

1. The Surgeon General. Charpter 9 Reproductive outcomes in The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. 459-521 (U. S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General, 2014).
2. The Surgeon General. Charpter 8 Cardiovascular diseases in The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. 411-458 (U. S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General, 2014).
3. Burns, D. M. Epidemiology of smoking-induced cardiovascular disease. Prog. Cardiovasc. Dis. 46, 11-29 (2003).
4. Peters, R. W., Brooks, M. M., Todd, L., Liebson, P. R. & Wilhelmsen, L. Smoking cessation and arrhythmic death: the CAST experience. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. J. Am. Coll. Cardiol. 26, 1287-1292 (1995).
5. Benowitz, N. L. Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog. Cardiovasc. Dis. 46, 91-111 (2003).
6. Miura, N., Yuki, D., Minami, N., Kakehi, A. & Onozawa, M. Pharmacokinetic analysis of nicotine when using non-combustion inhaler type of tobacco product in Japanese adult male smokers. Regul. Toxicol. Pharmacol. 67, 198-205 https://doi. org/10. 1016/j. yrtph. 2013. 07. 008 (2013).
7. Brent, R. L. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents). Pediatrics 113, 984-995 https://doi. org/10. 1002/bdrb. 20020 (2004).
8. Matta, S. G. et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl.) 190, 269-319 https://doi. org/10. 1007/s00213-006-0441-0 (2007).
9. Porchet, H. C., Benowitz, N. L., Sheiner, L. B. & Copeland, J. R. Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics. J. Clin. Invest. 80, 1466-1471 https://doi. org/10. 1172/JCI113227 (1987).
10. The Surgeon General. Charpter 8 Reproductive and developmental effects in How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease. A Report of the Surgeon General, 521-644 (U. S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General, 2010).
11. Shao, X. M. et al. Nicotine delivery to rats via lung alveolar region-targeted aerosol technology produces blood pharmacokinetics resembling human smoking. Nicotine Tob. Res. 15, 1248-1258 https://doi. org/10. 1093/ntr/nts261 (2013).
12. Tabrizchi, R. & Pugsley, M. K. Methods of blood flow measurement in the arterial circulatory system. J. Pharmacol. Toxicol. Methods 44, 375-384 (2000).
13. EPA. Health Effects Test Guidelines: Acute Inhalation Toxicity. (The Office of Prevention, Pesticides and Toxic Substances, United States Environmental Protection Agency, 1998).
14. OECD. OECD guidance document on acute inhalation toxicity testing in OECD Environment, Health and Safety Publications Series on Testing and Assessment 1-71 (The Environment, Health and Safety Division, Organization for Economic Co-operation and Development (OECD), 2009).
15. Lunell, E., Molander, L., Ekberg, K. & Wahren, J. Site of nicotine absorption from a vapour inhaler-comparison with cigarette smoking. Eur. J. Clin. Pharmacol. 55, 737-741 https://doi. org/10. 1007/s002280050007 (2000).
16. Hukkanen, J., Jacob, P. III & Benowitz, N. L. Metabolism and disposition kinetics of nicotine. Pharmacol. Rev. 57, 79-115 https:// doi. org/10. 1124/pr. 57. 1. 3 (2005).
17. Hutchison, S. M., Tietz, A. E., Trostel, K. A. & Schramm, L. P. Uterine arterial vasoconstrictions mediated by ovarian nerves in virgin and postpartum rats. Am. J. Physiol. 272, R318-325 (1997).
18. Hammer, R. E., Goldman, H. & Mitchell, J. A. Effects of nicotine on uterine blood flow and intrauterine oxygen tension in the rat. J. Reprod. Fertil. 63, 163-168 (1981).
19. Lang, U. et al. Uterine blood flow-a determinant of fetal growth. Eur. J. Obstet. Gynecol. Reprod. Biol. 110(Suppl 1), S55-61 (2003).
20. Neff, R. A., Humphrey, J., Mihalevich, M. & Mendelowitz, D. Nicotine enhances presynaptic and postsynaptic glutamatergic neurotransmission to activate cardiac parasympathetic neurons. Circ. Res. 83, 1241-1247 (1998).
21. Kamendi, H. et al. Prenatal nicotine exposure alters the nicotinic receptor subtypes that modulate excitation of parasympathetic cardiac neurons in the nucleus ambiguus from primarily alpha3beta2 and/or alpha6betaX to alpha3beta4. Neuropharmacology 51, 60-66 https://doi. org/10. 1016/j. neuropharm. 2006. 03. 001 (2006).
22. Bibevski, S., Zhou, Y., McIntosh, J. M., Zigmond, R. E. & Dunlap, M. E. Functional nicotinic acetylcholine receptors that mediate ganglionic transmission in cardiac parasympathetic neurons. J. Neurosci. 20, 5076-5082 (2000).
23. The Surgeon General. Chapter 3 Chemistry and toxicology of cigarette smoke and biomarkers of exposure and harm in How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease. A Report of the Surgeon General 27-102 (U. S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General, 2010).
24. Hayashi, H. et al. Age-related sensitivity to nicotine for inducible atrial tachycardia and atrial fibrillation. Am. J. physiol. Heart and circulatory physiology 285, H2091-2098 https://doi. org/10. 1152/ajpheart. 00371. 2003 (2003).
25. Wang, H. et al. Nicotine is a potent blocker of the cardiac A-type K(+) channels. Effects on cloned Kv4. 3 channels and native transient outward current. Circulation 102, 1165-1171 (2000).
26. Wang, H. Z., Shi, H., Liao, S. J. & Wang, Z. Inactivation gating determines nicotine blockade of human HERG channels. Am. J. Physiol. 277, H1081-1088 (1999).
27. Mehta, M. C., Jain, A. C., Mehta, A. & Billie, M. Cardiac Arrhythmias Following Intravenous Nicotine: Experimental Study in Dogs. J. Cardiovasc. Pharmacol. Ther. 2, 291-298 (1997).
28. Barron, K. W., Heesch, C. M., Fleming, B. P., Chien, C. Y. & Diana, J. N. Effects of chronic smoke exposure on the cardiovascular responses to acute nicotine infusion in the rat. Eur. J. Pharmacol. 146, 237-245 (1988).
29. Hinds, W. C. Aerosol Technology: properties, behavior, and measurement of airborne particles. 2nd edn, (John Wiley & Sons, Inc., 1999).
30. Drost, C. J. Vessel Diameter-Independent Volume Flow Measurements Using Ultrasound. Proceedings San Diego Biomedical Symposium 17, 299-302 (1978).
31. Shao, X. & Chen, P. X. Normalized auto-and cross-covariance functions for neuronal spike train analysis. Int. J. Neurosci. 34, 85-95 (1987).